NO20071238L - Fremgangsmater for leging av skader ved human IL-18 administrering - Google Patents

Fremgangsmater for leging av skader ved human IL-18 administrering

Info

Publication number
NO20071238L
NO20071238L NO20071238A NO20071238A NO20071238L NO 20071238 L NO20071238 L NO 20071238L NO 20071238 A NO20071238 A NO 20071238A NO 20071238 A NO20071238 A NO 20071238A NO 20071238 L NO20071238 L NO 20071238L
Authority
NO
Norway
Prior art keywords
human
administration
methods
healing damage
healing
Prior art date
Application number
NO20071238A
Other languages
English (en)
Inventor
Judithann Lee
Kimberly A Dede
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20071238L publication Critical patent/NO20071238L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen er generelt relatert til anvendelsen av humant IL- 18, også kjent som interferon-?-induserende faktor (IGIF), i behandlingen av hudskader, kirurgiske skader, leggssår, diabetessår, gastrointestinal mukositt, oral mukositt og lungeskader.
NO20071238A 2004-08-20 2007-03-07 Fremgangsmater for leging av skader ved human IL-18 administrering NO20071238L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60301204P 2004-08-20 2004-08-20
PCT/US2005/029358 WO2006023623A2 (en) 2004-08-20 2005-08-18 Methods of healing wounds by administering human il-18

Publications (1)

Publication Number Publication Date
NO20071238L true NO20071238L (no) 2007-05-14

Family

ID=35968167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071238A NO20071238L (no) 2004-08-20 2007-03-07 Fremgangsmater for leging av skader ved human IL-18 administrering

Country Status (23)

Country Link
US (1) US7595039B2 (no)
EP (2) EP1793859B1 (no)
JP (1) JP4912306B2 (no)
KR (1) KR20070050924A (no)
CN (1) CN101039696B (no)
AT (2) ATE426410T1 (no)
AU (1) AU2005277404A1 (no)
BR (1) BRPI0514445A (no)
CA (1) CA2577777A1 (no)
CY (1) CY1108991T1 (no)
DE (1) DE602005013542D1 (no)
DK (1) DK1793859T3 (no)
ES (2) ES2372728T3 (no)
IL (1) IL181286A0 (no)
MX (1) MX2007002134A (no)
NO (1) NO20071238L (no)
NZ (1) NZ552837A (no)
PL (1) PL1793859T3 (no)
PT (1) PT1793859E (no)
RU (1) RU2387455C2 (no)
SI (1) SI1793859T1 (no)
WO (1) WO2006023623A2 (no)
ZA (1) ZA200700524B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL356836A1 (en) * 2000-02-10 2004-07-12 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
RU2423971C1 (ru) * 2010-06-01 2011-07-20 Закрытое акционерное общество "Биологические исследования и системы" Способ ускорения заживления кожных повреждений, вызванных денервацией и нарушением кровоснабжения
US9925246B2 (en) 2011-06-13 2018-03-27 Neumedicines, Inc. Mitigation of cutaneous injury with IL-12
PT3041864T (pt) * 2013-09-05 2021-10-26 Ab2 Bio Sa Proteína de ligação a il-18 (il-18bp) em doenças inflamatórias
UA128752C2 (uk) 2015-03-05 2024-10-16 Аб2 Біо Са Фармацевтична композиція для лікування асоційованого з il-18 захворювання або порушення
US20190070262A1 (en) 2017-09-06 2019-03-07 Yale University Interleukin-18 variants and methods of use
JP2025508823A (ja) 2022-02-23 2025-04-10 ブライト ピーク セラピューティクス エージー 免疫抗原特異的ｉｌ－１８免疫サイトカイン及びその使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69519454T2 (de) 1994-07-14 2001-05-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
TW581771B (en) 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US5680795A (en) 1995-07-05 1997-10-28 Norco Inc. Mechanical drive assembly incorporating counter-spring biassed radially-adjustable rollers
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
US6491904B1 (en) * 1998-03-07 2002-12-10 Daewoong Pharmaceutical Co., Ltd. Topical composition containing human epidermal growth factor
TWI227136B (en) * 1998-05-21 2005-02-01 Smithkline Beecham Corp Novel pharmaceutical composition for the prevention and/or treatment of cancer
CN1457258A (zh) * 2000-06-02 2003-11-19 史密丝克莱恩比彻姆公司 用il－18和il－18组合物治疗病毒性疾病的方法
PL366134A1 (en) * 2000-06-15 2005-01-24 Smithkline Beecham Corporation Method for preparing a physiologically active il-18 polypeptide
ES2372030T3 (es) * 2001-07-12 2012-01-13 Taiho Pharmaceutical Co., Ltd. Animal transgénico il-18.
CN1694720A (zh) * 2002-09-16 2005-11-09 阿根尼克斯有限公司 乳铁蛋白组合物和创伤治疗的方法
WO2004031276A2 (en) * 2002-09-19 2004-04-15 Centocor, Inc. Method of inducing maturation of dendritic cells and uses therefor
WO2005018542A2 (en) * 2003-07-10 2005-03-03 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects

Also Published As

Publication number Publication date
RU2007110166A (ru) 2008-09-27
DK1793859T3 (da) 2009-06-22
KR20070050924A (ko) 2007-05-16
CN101039696B (zh) 2011-08-17
US7595039B2 (en) 2009-09-29
PL1793859T3 (pl) 2009-08-31
CN101039696A (zh) 2007-09-19
CA2577777A1 (en) 2006-03-02
WO2006023623A3 (en) 2006-08-24
BRPI0514445A (pt) 2008-06-10
EP1793859A4 (en) 2008-02-13
CY1108991T1 (el) 2014-07-02
DE602005013542D1 (de) 2009-05-07
ES2372728T3 (es) 2012-01-25
ATE526057T1 (de) 2011-10-15
RU2387455C2 (ru) 2010-04-27
NZ552837A (en) 2009-09-25
WO2006023623A2 (en) 2006-03-02
ZA200700524B (en) 2008-05-28
JP4912306B2 (ja) 2012-04-11
MX2007002134A (es) 2007-09-14
EP2161032B1 (en) 2011-09-28
JP2008510709A (ja) 2008-04-10
EP2161032A2 (en) 2010-03-10
ES2322605T3 (es) 2009-06-23
US20060039892A1 (en) 2006-02-23
AU2005277404A1 (en) 2006-03-02
PT1793859E (pt) 2009-06-04
HK1109054A1 (en) 2008-05-30
ATE426410T1 (de) 2009-04-15
EP2161032A3 (en) 2010-07-28
EP1793859B1 (en) 2009-03-25
SI1793859T1 (sl) 2009-06-30
EP1793859A2 (en) 2007-06-13
IL181286A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
IL181286A0 (en) Methods of healing wounds by administering human il-18
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
MY129079A (en) Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
AR045865A1 (es) El uso de un polifenol para el tratamiento de una lesion cancerosa o pre-cancerosa de la piel
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
BR0101486A (pt) Composições farmacêuticas de uso tópico, aplicadas no tratamento de lesões de pele e/ou mucosas; uso das composições no tratamento de lesões de pele e/ou mucosas e uso de compostos no tratamento de lesões de pele e/ou mucosas
NO20075199L (no) Treatment or prevention of pruritus
DE602004010691D1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen
DE502004011874D1 (de) Flupirtine-präparat zur behandlung von neurodegeneetes mellitus
DE50310383D1 (de) Humanes chondroosteomodulin (tig2), herstellung und verwendung zur behandlung oder diagnose von knochen- und knorpelerkrankungen, fettsucht sowie entzündlichen erkrankungen und hauterkrankungen
MX2025005174A (es) Formulacion oral de derivado de n-piridinilacetamida para tratar la enfermedad pulmonar intersticial
ATE468133T1 (de) Verwendung von g-csf als zusätzliche behandlung in die wiederherstellung von bindegewebe
ATE532512T1 (de) Isoniazid-vermittelte heilung von wunden und geschwüren
ATE425765T1 (de) Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen
TR200301800A2 (tr) Bir farmasötik terkip.
MX2007007304A (es) Aceite regenerador celular.
NO20064828L (no) Ny anvendelse av peptidforbindelser for behandling av smerte i smertefull diabetisk neuropati.
RU2004100497A (ru) Способ определния показаний к гипербарической оксигенации при лечении больных с острой ишемией конечностей после переломов длинных костей
YU17703A (sh) Nova farmaceutska kompozicija za primenu na koži
FI20021180A0 (fi) Lääketieteellisen tutkimus- ja käsittelypöydän jatkesovitelma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application